A systematic approach to decipher crosstalk in the p53 signaling pathway using single cell dynamics

The transcription factors NF-κB and p53 are key regulators in the genotoxic stress response and are critical for tumor development. Although there is ample evidence for interactions between both networks, a comprehensive understanding of the crosstalk is lacking. Here, we developed a systematic approach to identify potential interactions between the pathways. We perturbed NF-κB signaling by inhibiting IKK2, a critical regulator of NF-κB activity, and monitored the altered response of p53 to genotoxic stress using single cell time lapse microscopy. Fitting subpopulation-specific computational p53 models to this time-resolved single cell data allowed to reproduce in a quantitative manner signaling dynamics and cellular heterogeneity for the unperturbed and perturbed conditions. The approach enabled us to untangle the integrated effects of IKK/ NF-κB perturbation on p53 dynamics and thereby derive potential interactions between both networks. Intriguingly, we find that a simultaneous perturbation of multiple processes is necessary to explain the observed changes in the p53 response. Specifically, we show interference with the activation and degradation of p53 as well as the degradation of Mdm2. Our results highlight the importance of the crosstalk and its potential implications in p53-dependent cellular functions.

[1]  I. Verma,et al.  Phosphorylation of p53 by IκB kinase 2 promotes its degradation by β-TrCP , 2009, Proceedings of the National Academy of Sciences.

[2]  G. K. Gray,et al.  NF-κB-Induced IL-6 Ensures STAT3 Activation and Tumor Aggressiveness in Glioblastoma , 2013, PloS one.

[3]  D. Lane,et al.  Regulation of the specific DNA binding function of p53 , 1992, Cell.

[4]  Xiao-Fan Wang,et al.  Signaling cross-talk between TGF-β/BMP and other pathways , 2009, Cell Research.

[5]  A. Loewer,et al.  Cell‐specific responses to the cytokine TGFβ are determined by variability in protein levels , 2018, Molecular systems biology.

[6]  Fabian J. Theis,et al.  Data2Dynamics: a modeling environment tailored to parameter estimation in dynamical systems , 2015, Bioinform..

[7]  Thomas S. Ligon,et al.  Multi-experiment nonlinear mixed effect modeling of single-cell translation kinetics after transfection , 2018, npj Systems Biology and Applications.

[8]  Eugenio Cinquemani,et al.  What Population Reveals about Individual Cell Identity: Single-Cell Parameter Estimation of Models of Gene Expression in Yeast , 2016, PLoS Comput. Biol..

[9]  K. Vousden,et al.  p53 mutations in cancer , 2013, Nature Cell Biology.

[10]  C. Dieterich,et al.  Disorder and residual helicity alter p53-Mdm2 binding affinity and signaling in cells. , 2014, Nature chemical biology.

[11]  Dirk Drasdo,et al.  Modeling Dynamics of Cell-to-Cell Variability in TRAIL-Induced Apoptosis Explains Fractional Killing and Predicts Reversible Resistance , 2014, PLoS Comput. Biol..

[12]  G. Wahl,et al.  p53 stabilization is decreased upon NFκB activation , 2002 .

[13]  Andrea Ciliberto,et al.  Steady States and Oscillations in the p53/Mdm2 Network , 2005, Cell cycle.

[14]  Fabian J Theis,et al.  Lessons Learned from Quantitative Dynamical Modeling in Systems Biology , 2013, PloS one.

[15]  R. Milo,et al.  Oscillations and variability in the p53 system , 2006, Molecular systems biology.

[16]  Kwang-Hyun Cho,et al.  Attractor Landscape Analysis Reveals Feedback Loops in the p53 Network That Control the Cellular Response to DNA Damage , 2012, Science Signaling.

[17]  S. Pomeroy,et al.  UBE4B promotes Hdm2-mediated degradation of the tumor suppressor p53 , 2011, Nature Medicine.

[18]  R. Milo,et al.  Dynamic Proteomics of Individual Cancer Cells in Response to a Drug , 2008, Science.

[19]  Jeremy E. Purvis,et al.  p53 Dynamics Control Cell Fate , 2012, Science.

[20]  L. Mayo,et al.  A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[21]  Michael Karin,et al.  Positive and Negative Regulation of IκB Kinase Activity Through IKKβ Subunit Phosphorylation , 1999 .

[22]  Qian Yang,et al.  Nuclear Factor-κB (NF-κB) Is a Novel Positive Transcriptional Regulator of the Oncogenic Wip1 Phosphatase* , 2009, The Journal of Biological Chemistry.

[23]  R. Seifert,et al.  Selectivity of pharmacological tools: implications for use in cell physiology. A review in the theme: Cell signaling: proteins, pathways and mechanisms. , 2015, American journal of physiology. Cell physiology.

[24]  T. Hirano,et al.  Ionizing radiation induces expression of interleukin 6 by human fibroblasts involving activation of nuclear factor-kappa B. , 1993, The Journal of biological chemistry.

[25]  E. Appella,et al.  Wip1 phosphatase modulates ATM-dependent signaling pathways. , 2006, Molecular cell.

[26]  R. Lau,et al.  cIAP2 represses IKKα/β-mediated activation of MDM2 to prevent p53 degradation , 2012, Cell cycle.

[27]  Kwang-Hyun Cho,et al.  The crossregulation between ERK and PI3K signaling pathways determines the tumoricidal efficacy of MEK inhibitor. , 2012, Journal of molecular cell biology.

[28]  G. Wahl,et al.  Accelerated MDM2 auto‐degradation induced by DNA‐damage kinases is required for p53 activation , 2004, The EMBO journal.

[29]  Douglas B. Evans,et al.  Stabilization of p53 is a novel mechanism for proapoptotic function of NF-kappaB. , 2004, Journal of Biological Chemistry.

[30]  Qifeng Bai,et al.  TPCA-1 Is a Direct Dual Inhibitor of STAT3 and NF-κB and Regresses Mutant EGFR-Associated Human Non–Small Cell Lung Cancers , 2014, Molecular Cancer Therapeutics.

[31]  D. Lane.  Worrying about p53 , 1992, Current Biology.

[32]  Alessandra Cambi,et al.  The Tetraspanin CD37 Orchestrates the α4β1 Integrin–Akt Signaling Axis and Supports Long-Lived Plasma Cell Survival , 2012, Science Signaling.

[33]  Xi Chen,et al.  DNA damage strength modulates a bimodal switch of p53 dynamics for cell-fate control , 2013, BMC Biology.

[34]  C. Scheidereit.  IkappaB kinase complexes: gateways to NF-kappaB activation and transcription. , 2006, Oncogene.

[35]  Xin Lu,et al.  Live or let die: the cell's response to p53 , 2002, Nature Reviews Cancer.

[36]  Wei Gu,et al.  Modes of p53 Regulation , 2009, Cell.

[37]  Pei-Ming Yang,et al.  Loss of IKKβ activity increases p53 stability and p21 expression leading to cell cycle arrest and apoptosis , 2009, Journal of cellular and molecular medicine.

[38]  Peng Huang,et al.  Stabilization of p53 Is a Novel Mechanism for Proapoptotic Function of NF-κB* , 2004, Journal of Biological Chemistry.

[39]  Galit Lahav,et al.  Stimulus-dependent dynamics of p53 in single cells , 2011, Molecular systems biology.

[40]  A. Loewer,et al.  Hyperactivation of ATM upon DNA-PKcs inhibition modulates p53 dynamics and cell fate in response to DNA damage , 2016, Molecular biology of the cell.

[41]  P. Sorger,et al.  Non-genetic origins of cell-to-cell variability in TRAIL-induced apoptosis , 2009, Nature.

[42]  R. Leng,et al.  UBE4B targets phosphorylated p53 at serines 15 and 392 for degradation , 2015, Oncotarget.

[43]  S. Ghosh,et al.  Crosstalk in NF-κB signaling pathways , 2011, Nature Immunology.

[44]  Torsten Wittmann,et al.  Fluorescence live cell imaging. , 2014, Methods in cell biology.

[45]  S. Elledge,et al.  The DNA damage response: making it safe to play with knives. , 2010, Molecular cell.

[46]  G. Lahav,et al.  Recurrent initiation: a mechanism for triggering p53 pulses in response to DNA damage. , 2008, Molecular cell.

[47]  G. Dittmar,et al.  A cytoplasmic ATM-TRAF6-cIAP1 module links nuclear DNA damage signaling to ubiquitin-mediated NF-κB activation. , 2010, Molecular cell.

[48]  S. Ghosh,et al.  Shared Principles in NF-κB Signaling , 2008, Cell.

[49]  J. Schmid,et al.  The complexity of NF-κB signaling in inflammation and cancer , 2013, Molecular Cancer.

[50]  Hua Yu,et al.  Role of Stat3 in Regulating p53 Expression and Function , 2005, Molecular and Cellular Biology.

[51]  C. Prives,et al.  Blinded by the Light: The Growing Complexity of p53 , 2009, Cell.

[52]  S. Ghosh,et al.  The NF-kappaB family of transcription factors and its regulation. , 2009, Cold Spring Harbor perspectives in biology.

[53]  D. Lauffenburger,et al.  Measurement and modeling of signaling at the single-cell level. , 2012, Biochemistry.

[54]  Joonhee Kim,et al.  Modification of serine 392 is a critical event in the regulation of p53 nuclear export and stability , 2004, FEBS letters.

[55]  G. Wahl,et al.  p53 stabilization is decreased upon NFkappaB activation: a role for NFkappaB in acquisition of resistance to chemotherapy. , 2002, Cancer cell.

[56]  M. Oren,et al.  Mdm2 promotes the rapid degradation of p53 , 1997, Nature.

[57]  G. Lahav,et al.  We are all individuals: causes and consequences of non-genetic heterogeneity in mammalian cells. , 2011, Current opinion in genetics & development.

[58]  M. Karin,et al.  Positive and negative regulation of IkappaB kinase activity through IKKbeta subunit phosphorylation. , 1999, Science.

[59]  U Alon,et al.  Generation of oscillations by the p53-Mdm2 feedback loop: a theoretical and experimental study. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[60]  Eric Batchelor,et al.  Recent progress and open challenges in modeling p53 dynamics in single cells. , 2017, Current opinion in systems biology.

[61]  Y Taya,et al.  Enhanced phosphorylation of p53 by ATM in response to DNA damage. , 1998, Science.

[62]  Uri Alon,et al.  Dynamics of the p53-Mdm2 feedback loop in individual cells , 2004, Nature Genetics.

[63]  H. Sakamoto,et al.  Phosphorylation of serine 392 stabilizes the tetramer formation of tumor suppressor protein p53. , 1997, Biochemistry.

[64]  James F. Callahan,et al.  Attenuation of Murine Collagen-Induced Arthritis by a Novel, Potent, Selective Small Molecule Inhibitor of IκB Kinase 2, TPCA-1 (2-[(Aminocarbonyl)amino]-5-(4-fluorophenyl)-3-thiophenecarboxamide), Occurs via Reduction of Proinflammatory Cytokines and Antigen-Induced T Cell Proliferation , 2005, Journal of Pharmacology and Experimental Therapeutics.

[65]  Jens Timmer,et al.  L1 regularization facilitates detection of cell type-specific parameters in dynamical systems , 2016, Bioinform..

[66]  Anne E Carpenter,et al.  CellProfiler: image analysis software for identifying and quantifying cell phenotypes , 2006, Genome Biology.

[67]  Ying Yang,et al.  IKKβ activates p53 to promote cancer cell adaptation to glutamine deprivation , 2018, Oncogenesis.

[68]  Yoichi Taya,et al.  DNA Damage-Induced Phosphorylation of p53 Alleviates Inhibition by MDM2 , 1997, Cell.

[69]  B. Snijder,et al.  Origins of regulated cell-to-cell variability , 2011, Nature Reviews Molecular Cell Biology.

[70]  P. Cohen,et al.  The selectivity of protein kinase inhibitors: a further update. , 2007, The Biochemical journal.

[71]  Scott W. Lowe,et al.  Putting p53 in Context , 2017, Cell.